Clinical Trials Logo

Filter by:
NCT ID: NCT05852769 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

Start date: May 31, 2023
Phase: Phase 1
Study type: Interventional

This study is designed to assess the effect of BMS-986196 on the drug levels of caffeine, montelukast, flurbiprofen, omeprazole, midazolam, digoxin, and pravastatin in healthy participants.

NCT ID: NCT05852470 Completed - Aphakia Clinical Trials

Evaluation of Clareon Vivity/Vivity Toric

Start date: May 23, 2023
Phase: N/A
Study type: Interventional

This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Clareon Vivity Toric IOLs or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits with model-specific data.

NCT ID: NCT05851872 Completed - Heart Diseases Clinical Trials

Fasting Versus Non-fasting on Outcomes and Satisfaction Prior to Cardiac Catheterization

CALORI (NPO)
Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Moderate sedation is used in the catheterization laboratory relieve the anxiety and discomfort associated with access and other aspects of the procedure. Whether being in a fasting state (nothing per os, NPO) at the time of the procedure is beneficial or harmful is not well known, but patients are typically required to be fasting at the time of elective procedures, guidance derived from procedures that require general anesthesia. Whereas the typical thinking was that fasting prior to procedures would minimize the risk of aspiration in the event of intubation, or nausea and other symptoms generally, several studies have shown that prolonged fasting prior to procedures is associated with increased nausea, vomiting, aspiration and procedure recovery time. We aim to evaluate patient satisfaction, nausea and immediate outcomes of patients who are not kept NPO prior to cardiac catheterization.

NCT ID: NCT05851573 Completed - Stroke Clinical Trials

Stepped Care for Aphasia

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

This study is recruiting people who had a stroke at least 1 month ago and now have a language impairment called aphasia. Living with aphasia can have devastating effects on communication and quality of life, and it is not uncommon for survivors with aphasia to face psychological problems like depression and anxiety. Participants who are eligible for this study will undergo baseline testing, engage in a 5-week treatment focused on psychological well-being, undergo post-treatment testing, and then testing again 1-month later. Check-in phone calls will be conducted during the 1-month off period and participants will be interviewed about their experience at the end of the study as well. Compensation will be provided to participants with aphasia.

NCT ID: NCT05851157 Completed - Pain Clinical Trials

A Study to Evaluate the Effect of Food on the Pharmacokinetics of VX-548

Start date: May 3, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-548 in healthy participants.

NCT ID: NCT05850533 Completed - Anxiety Clinical Trials

Tai Chi Easy for Opioid Use Disorder, Anxiety, and Chronic Pain

Start date: May 22, 2023
Phase: N/A
Study type: Interventional

A pre-post, single-group, quasi-experimental design will be used to determine the acceptability, feasibility, and appropriateness of a theory-based, 8-week/16-session virtual Tai Chi Easy (vTCE) intervention for adults with OUD, anxiety, and chronic pain. This dissertation has three Aims: 1) Determine the feasibility of an 8-week/16-session, vTCE intervention for adults with OUD, CP, and anxiety; 2) Determine the perceptions of the vTCE intervention participants by conducting a focus group interview post-vTCE; 3) Explore within-subject changes in generalized anxiety, chronic pain intensity, opioid use, opioid cravings, and basic psychological needs post-vTCE.

NCT ID: NCT05850494 Completed - Asthma Clinical Trials

Study to Assess Bronchospasm Potentially Induced by HFO vs HFA MDI in Participants With Well/Partially Controlled Asthma

Start date: May 2, 2023
Phase: Phase 3
Study type: Interventional

A study to assess bronchospasm potentially induced by HFO MDI as compared with HFA MDI in participants with well controlled or partially controlled asthma

NCT ID: NCT05850221 Completed - Depression Clinical Trials

Anaerobic Exercise and Mental Acuity

Start date: April 15, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to examine the effect of anaerobic activity (e.g., weight training) on gut microbiome metabolism and neurological health in healthy sedentary men.

NCT ID: NCT05849935 Completed - Sepsis Clinical Trials

abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003

AB-PSP-007
Start date: July 17, 2023
Phase:
Study type: Observational

This is a monocentric, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.

NCT ID: NCT05849051 Completed - Tobacco Use Clinical Trials

Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs

Start date: May 22, 2023
Phase: N/A
Study type: Interventional

The goal of this research is to assess whether little Cigars and cigarillos (LCC) warnings developed by the study team are more effective than the current warnings proposed by FDA for LCC products. A 3-week web-based randomized controlled trial will be conducted in the United States. Participants are adult persons who currently use LCCs.